OCWP
TAK icon

Owl Creek Wealth Partners’s Takeda Pharmaceutical TAK Stock Holding History

Owl Creek Wealth Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9K Sell
3,240
-90
-3% -$1.49K 0.02% 351
2026
Q1 		$61.7K Buy
+3,330
New +$58.4K 0.02% 282

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Owl Creek Wealth Partners's TAK Position: Q2 2026 in Review

Owl Creek Wealth Partners reduced its Takeda Pharmaceutical (TAK) stake by 2.7% in Q2 2026, selling an estimated $1.49K and leaving 3,240 shares worth $51.9K. The position accounts for 0.02% of the portfolio, ranked #351.

Owl Creek Wealth Partners first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $61.7K in Q1 2026. 357 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Owl Creek Wealth Partners held 3,240 shares of Takeda Pharmaceutical worth $51.9K as of Q2 2026.
  • Owl Creek Wealth Partners sold 90 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.49K.
  • Takeda Pharmaceutical made up 0.02% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #351 holding.
  • Owl Creek Wealth Partners first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Takeda Pharmaceutical position peaked at $61.7K in Q1 2026.
  • 357 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.